-
1
-
-
0023195303
-
Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastin or etoposide
-
1 Williams SD, Birch R, Einhorn LH. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastin or etoposide. N. Engl. J. Med. 1987; 316: 1435-40.
-
(1987)
N. Engl. J. Med.
, vol.316
, pp. 1435-1440
-
-
Williams, S.D.1
Birch, R.2
Einhorn, L.H.3
-
2
-
-
0023695848
-
Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide
-
2 Loehrer PJ, Lauer R, Roth BJ, Williams SD, Kalasinski LA, Einhorn LH. Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide. Ann. Intern. Med. 1988; 109: 540-6.
-
(1988)
Ann. Intern. Med.
, vol.109
, pp. 540-546
-
-
Loehrer, P.J.1
Lauer, R.2
Roth, B.J.3
Williams, S.D.4
Kalasinski, L.A.5
Einhorn, L.H.6
-
3
-
-
0344734200
-
Vinblastine plus ifosfamidc plus cisplatin as initial salvage therapy in recurrent germ cell tumor
-
3 Loehrer PJ, Gonin SR, Nichols CR, Weathers T, Einhorn LH. Vinblastine plus ifosfamidc plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J. Clin. Oncol. 1981; 16: 2500-4.
-
(1981)
J. Clin. Oncol.
, vol.16
, pp. 2500-2504
-
-
Loehrer, P.J.1
Gonin, S.R.2
Nichols, C.R.3
Weathers, T.4
Einhorn, L.H.5
-
4
-
-
0026459668
-
High-dose chemotherapy for resistant germ cell tumors: Recent advances and future directions
-
4 Motzer RJ, Bosl GJ. High-dose chemotherapy for resistant germ cell tumors: Recent advances and future directions. J. Natl Cancer Inst. 1992; 84: 1703-9.
-
(1992)
J. Natl Cancer Inst.
, vol.84
, pp. 1703-1709
-
-
Motzer, R.J.1
Bosl, G.J.2
-
5
-
-
0022576065
-
Prognostic factors for favorable outcome in disseminated germ cell tumors
-
5 Birch R, Williams S, Cone A et al. Prognostic factors for favorable outcome in disseminated germ cell tumors. J. Clin. Oncol. 1986; 4: 400-7.
-
(1986)
J. Clin. Oncol.
, vol.4
, pp. 400-407
-
-
Birch, R.1
Williams, S.2
Cone, A.3
-
6
-
-
0008552573
-
MAC therapy for refractory testicular cancer
-
Etsuji Takasaki (ed.), 5-6 November 1994, Tochigi, Japan. Etsuji Takasaki, Tochigi; Abstract
-
6 Hayashi H, Akaza H, Koiso K. MAC therapy for refractory testicular cancer. In: Etsuji Takasaki (ed.). Regional Meeting of East Japanese Urological Association, 5-6 November 1994, Tochigi, Japan. Etsuji Takasaki, Tochigi. 1994; 158 (Abstract).
-
(1994)
Regional Meeting of East Japanese Urological Association
, pp. 158
-
-
Hayashi, H.1
Akaza, H.2
Koiso, K.3
-
7
-
-
0008614026
-
A proposal for new toxicity grading criteria by the Japan Society for Cancer Therapy
-
7 Japan Clinical Oncology Group. A proposal for new toxicity grading criteria by the Japan Society for Cancer Therapy. J. Jpn Soc. Cancer Ther. 1995; 30: 1957-62.
-
(1995)
J. Jpn Soc. Cancer Ther.
, vol.30
, pp. 1957-1962
-
-
-
8
-
-
0027489607
-
Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors
-
8 Motzer RJ, Mazumdar M, Gulati SC et al. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J. Natl Cancer Inst. 1993; 85: 1828-35.
-
(1993)
J. Natl Cancer Inst.
, vol.85
, pp. 1828-1835
-
-
Motzer, R.J.1
Mazumdar, M.2
Gulati, S.C.3
-
9
-
-
0024338525
-
Dose-intensive chemotherapy in refractory germ cell cancer: A phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation
-
9 Nichols CR, Tricot G, Williams SD et al. Dose-intensive chemotherapy in refractory germ cell cancer: A phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J. Clin. Oncol. 1989; 7: 932-9.
-
(1989)
J. Clin. Oncol.
, vol.7
, pp. 932-939
-
-
Nichols, C.R.1
Tricot, G.2
Williams, S.D.3
-
10
-
-
0029928705
-
High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: Treatment results and prognostic factors for survival and toxicity
-
10 Motzer RJ, Mazumdar M, Bosl GJ, Bajorin DF, Amsterdam A, Vlamis V. High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: Treatment results and prognostic factors for survival and toxicity. J. Clin. Oncol. 1996; 14: 1098-105.
-
(1996)
J. Clin. Oncol.
, vol.14
, pp. 1098-1105
-
-
Motzer, R.J.1
Mazumdar, M.2
Bosl, G.J.3
Bajorin, D.F.4
Amsterdam, A.5
Vlamis, V.6
-
11
-
-
0026580199
-
High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors
-
11 Motzer RJ, Gulati SC, Crown JP et al. High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Cancer 1992; 69: 550-6.
-
(1992)
Cancer
, vol.69
, pp. 550-556
-
-
Motzer, R.J.1
Gulati, S.C.2
Crown, J.P.3
-
12
-
-
10144262544
-
High-dose chemotherapy as salvage treatment in germ cell tumors: A multivariate analysis of prognostic variables
-
12 Beyer J, Kramar A, Mandanas R et al. High-dose chemotherapy as salvage treatment in germ cell tumors: A multivariate analysis of prognostic variables. J. Clin. Oncol. 1996; 14: 2638-45.
-
(1996)
J. Clin. Oncol.
, vol.14
, pp. 2638-2645
-
-
Beyer, J.1
Kramar, A.2
Mandanas, R.3
-
13
-
-
0030804929
-
High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors
-
13 Motzer RJ, Mazumdar M, Bajorin DF, Bosl GJ, Lyn P, Vlamis V. High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J. Clin. Oncol. 1997; 15: 2546-52.
-
(1997)
J. Clin. Oncol.
, vol.15
, pp. 2546-2552
-
-
Motzer, R.J.1
Mazumdar, M.2
Bajorin, D.F.3
Bosl, G.J.4
Lyn, P.5
Vlamis, V.6
-
14
-
-
0028330834
-
Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support
-
14 Broun ER, Nichols CR, Turns M et al. Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support. Cancer 1994; 73: 1716-20.
-
(1994)
Cancer
, vol.73
, pp. 1716-1720
-
-
Broun, E.R.1
Nichols, C.R.2
Turns, M.3
|